Hester Biosciences receives WHO GMP Certification for poultry vaccines

11 Feb 2013 Evaluate

Hester Biosciences has received the WHO GMP Certification for poultry vaccines. This certification would help the company in hastening the registration process in many countries, as well as in opening the registration doors in the regulated markets.

Besides, the company is also in the process of launching its locally produced Bivalent Marek’s Disease Live vaccine containing HVT & SB1 strains. Currently, trails are being conducted. The market for this vaccine is approximately Rs 30 crore.

At present, nearly 50% of the vaccine requirement is imported. Hester’s local production of this vaccine will be an import replacement, besides providing a cost advantage to the Indian poultry farmers. Hester expects an overall growth of 25% in sales in this financial year, over last year.

Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×